Key result
The TT genotype of the angiotensinogen M235T polymorphism was significantly associated with an increased risk of myocardial infarction (OR 2.08; 95% CI 1.08-4.00; P=0.029).
Why the study?
Does the M235T polymorphism of the angiotensinogen gene increase the risk of myocardial infarction in Asian populations?
Case-Control (n=340)
No
Does the M235T polymorphism of the angiotensinogen gene increase the risk of myocardial infarction in Asian populations?
Odds Ratio: 2.08 (95% CI 1.08–4)
p-value: p=0.029
The M235T polymorphism of the angiotensinogen gene is significantly associated with an increased risk of myocardial infarction in Asian populations.
M235T TT genotype was associated with MI risk in Asians; leaves open whether genotyping improves risk stratification or warrants prospective validation.
AIM: To investigate if there is an association between M235T polymorphism of angiotensinogen gene and myocardial infarction (MI) risk and perform a meta-analysis and an in silico approach. METHODS: This case-control study included 340 participants (155 MI patients and 185 controls) examined at Kashan University of Medical Sciences (Kashan, Iran) between 2013 and 2015. Meta-analysis included 25 studies with 6334 MI patients and 6711 controls. Bioinformatics tools were applied to evaluate the impact of M235T polymorphism on angiotensinogen function and structure. RESULTS: Genetic association study revealed a significant association between TT genotype (odds ratio [OR] 2.08, 95% confidence interval [CI] 1.08-4.00, P=0.029) and T allele (OR 1.45, 95% CI 1.06-1.99, P=0.021) and MI risk. Meta-analysis also revealed a significant association between M235T polymorphism and MI risk in allelic (OR 1.55, 95% CI 1.10-2.18, P=0.012) and recessive (OR 1.69, 95% CI 1.13-2.53, P=0.010) models within Asian population. In silico-analysis revealed that M235T fundamentally changed the function of angiotensinogen (score 32; expected accuracy 66%). CONCLUSIONS: Our study suggests that M235T polymorphism might be a helpful biomarker for screening of susceptible individuals for MI in Asian population.
No takes yet. Share an insight, caveat, or question.
Raygan et al. (2016) conducted a case-control in myocardial infarction (n=340). M235T polymorphism of angiotensinogen gene (TT genotype) vs. Other genotypes / controls was evaluated on myocardial infarction risk (OR 2.08, 95% CI 1.08-4.00, p=0.029). The TT genotype of the angiotensinogen M235T polymorphism was significantly associated with an increased risk of myocardial infarction (OR 2.08; 95% CI 1.08-4.00; P=0.029).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: